You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model

Article Text

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Combination Immunotherapies
788 Improved immunologic and therapeutic activity of anchored interleukin (IL-12) immunotherapy in combination with cytotoxic chemotherapy and immune checkpoint inhibitor in a head and neck cancer model

https://doi.org/10.1136/jitc-2023-SITC2023.0788

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.